| Glycosyn | ||
GlycoSyn is your first-choice partner for the development and production of complex active pharmaceutical ingredients (APIs) for pre-clinical and clinical drug development programmes. |
GlycoSyn’s discovery division comprises more than 35 PhD synthetic organic chemists with wide ranging experience in carbohydrate, small molecule organic and peptide syntheses, rational drug design, and route selection. |
Prototype manufacture in one of GlycoSyn’s pilot laboratories provides larger quantities of drug substance for pre-clinical evaluation with full supporting documentation to facilitate subsequent clinical manufacture. |
| ORPEGEN Peptide Chemicals | ||
ORPEGEN Peptide Chemicals has in-house pharmaceutical GMP production capacity and knowledge of generic synthetic peptide hormones and thymic peptides; we cover lab-scale development to kilogram-scale GMP production. |
The manufacturing of amino acid derivates delivers up to 200kg per batch; each lot of amino acid derivatives is checked for enantiomeric purity, acetate and beta-alanine content, and is accompanied by a BSE/TSE risk-free certificate. |
ORPEGEN Peptide Chemicals continues the long history of ORPEGEN Pharma as a supplier of amino acid derivatives for both the pharmaceutical industry and research labs worldwide. |
ORPEGEN Peptide Chemicals is also a contract manufacturer for active pharmaceutical ingredients (APIs) with a focus on peptides and small molecules. |
||
| PolyPeptide Group | ||
Large capacity shelf freeze dryer for cGMP manufacturing. |
Purification station for research peptides. |
Column for large-scale purification. |
200l reactor for solid phase peptide synthesis. |
||